Acute HIV Infection
22
5
5
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.5%
1 terminated out of 22 trials
93.3%
+6.8% vs benchmark
27%
6 trials in Phase 3/4
36%
5 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (22)
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
Antiretroviral Therapy for Acute and Chronic HIV Infection
Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
Empiric Treatment for Acute HIV in the ED
Netherlands Cohort Study on Acute HIV Infection
Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection
Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
Specimen Repository for HIV Immunopathogenesis
Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection
Acute Partner and Social Contact Referral: iKnow
Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis
Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection
HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence